Friday, July 10, 2026

Drug profile · INN

tilmanocept

tilmanocept (LYMPHOSEEK) is a diagnostic agent.

EMA: withdrawn Various (V09) V09IA09
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — tilmanocept
Class
Various (V09)
Route
Patents
0
Programs
3
Data quality
0.83

Quick answer

tilmanocept (LYMPHOSEEK) is a diagnostic agent.

Key facts

INN tilmanocept
Brand LYMPHOSEEK
Mechanism Diagnostic agent
Therapeutic class Various (V09)
ATC code V09IA09

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
EMA withdrawn

Pipeline programs

  1. GALLIUM (68GA) CHLORIDE, TILMANOCEPT Phase 3 · Disc Medicine · Carcinoma of the parotid gland
  2. GALLIUM (68GA) CHLORIDE, TILMANOCEPT Phase 3 · Disc Medicine · Endometrial cancer, uterine cancer
  3. V0001699 Approved · Disc Medicine · Oral cancer

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is tilmanocept?

tilmanocept (LYMPHOSEEK) is a diagnostic agent.

What is the brand name for tilmanocept?

LYMPHOSEEK is a marketed brand name for tilmanocept. Check FDA Drugs@FDA for the current US label holder and prescribing information.